Ligand Pharmaceuticals Incorporated
NASDAQ: LGND0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Todd C. Davis
- Employees
- 68
- Headquarters
- Jupiter, United States
- IPO year
- 1992
- Market cap
- $5.5B
- Website
- https://www.ligand.com
Loading LGND…
Loading profile data…Frequently asked questions about LGND
What does Ligand Pharmaceuticals Incorporated (LGND) do?
Ligand Pharmaceuticals Incorporated operates as a biopharmaceutical entity, primarily engaged in sourcing and advancing technologies to empower pharmaceutical companies globally in their efforts to discover and develop novel therapeutic solutions. Its diverse portfolio of commercialized products addresses a wide range of medical conditions. For...
Where does LGND trade?
Ligand Pharmaceuticals Incorporated (LGND) trades on the NASDAQ Global Market.
What sector is LGND in?
Ligand Pharmaceuticals Incorporated (LGND) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Ligand Pharmaceuticals Incorporated?
Todd C. Davis is the chief executive officer of Ligand Pharmaceuticals Incorporated (LGND).
Where is Ligand Pharmaceuticals Incorporated headquartered?
Ligand Pharmaceuticals Incorporated is headquartered in United States.
Does LGND pay a dividend?
Ligand Pharmaceuticals Incorporated (LGND) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did LGND go public?
Ligand Pharmaceuticals Incorporated (LGND) completed its initial public offering in 1992.